Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M Cuchacovich

Showing results (31-40 of 38) with videos related to

Pageof 4
Sort By:
You have reached the last page of results.This site can display upto 38 results.
Clinical and Experimental Rheumatology|February 13, 2009
Basal anti-cyclic citrullinated peptide (anti-CCP) antibody levels and a decrease in anti-CCP titres are associated with clinical response to adalimumab in rheumatoid arthritisM Cuchacovich, D Catalan, E Wainstein, et al.
Rheumatology (Oxford, England)|February 22, 2003
The -308 polymorphism in the tumour necrosis factor (TNF) gene promoter region and ex vivo lipopolysaccharide-induced TNF expression and cytotoxic activity in Chilean patients with rheumatoid arthritisJ Cuenca, M Cuchacovich, C Pérez, et al.
Clinical and Experimental Rheumatology|November 9, 2005
Behçet's disease patients present high levels of deglycosylated anti-lipoteichoic acid IgG and high IL-8 production after lipoteichoic acid stimulationM Cuchacovich, G Merino, J H Yamamoto, et al.
Clinical and Experimental Rheumatology|November 1, 1994
Growth factor activity of IL-6 in the synovial fluid of patients with rheumatoid arthritisS Monier, T Rème, C Cognot, et al.
Clinical and Experimental Immunology|February 6, 2013
Effect of interleukin-6 receptor blockade on the balance between regulatory T cells and T helper type 17 cells in rheumatoid arthritis patientsB Pesce, L Soto, F Sabugo, et al.
Scandinavian Journal of Rheumatology|September 17, 2004
Tumour necrosis factor-alpha (TNF-alpha) levels and influence of -308 TNF-alpha promoter polymorphism on the responsiveness to infliximab in patients with rheumatoid arthritisM Cuchacovich, L Ferreira, M Aliste, et al.
Scandinavian Journal of Rheumatology|March 9, 2007
Tumour necrosis factor (TNF)alpha -308 G/G promoter polymorphism and TNFalpha levels correlate with a better response to adalimumab in patients with rheumatoid arthritisM Cuchacovich, L Soto, M Edwardes, et al.
Annals of the Rheumatic Diseases|December 7, 2007
Modulation of established murine collagen-induced arthritis by a single inoculation of short-term lipopolysaccharide-stimulated dendritic cellsL Salazar, O Aravena, P Abello, et al.
Pageof 4

Showing results (31-40 of 38) with videos related to

Sort By:
Pageof 4
You have reached the last page of results.This site can display upto 38 results.
Clinical and Experimental Rheumatology|February 13, 2009
Basal anti-cyclic citrullinated peptide (anti-CCP) antibody levels and a decrease in anti-CCP titres are associated with clinical response to adalimumab in rheumatoid arthritisM Cuchacovich, D Catalan, E Wainstein, et al.
Rheumatology (Oxford, England)|February 22, 2003
The -308 polymorphism in the tumour necrosis factor (TNF) gene promoter region and ex vivo lipopolysaccharide-induced TNF expression and cytotoxic activity in Chilean patients with rheumatoid arthritisJ Cuenca, M Cuchacovich, C Pérez, et al.
Clinical and Experimental Rheumatology|November 9, 2005
Behçet's disease patients present high levels of deglycosylated anti-lipoteichoic acid IgG and high IL-8 production after lipoteichoic acid stimulationM Cuchacovich, G Merino, J H Yamamoto, et al.
Clinical and Experimental Rheumatology|November 1, 1994
Growth factor activity of IL-6 in the synovial fluid of patients with rheumatoid arthritisS Monier, T Rème, C Cognot, et al.
Clinical and Experimental Immunology|February 6, 2013
Effect of interleukin-6 receptor blockade on the balance between regulatory T cells and T helper type 17 cells in rheumatoid arthritis patientsB Pesce, L Soto, F Sabugo, et al.
Scandinavian Journal of Rheumatology|September 17, 2004
Tumour necrosis factor-alpha (TNF-alpha) levels and influence of -308 TNF-alpha promoter polymorphism on the responsiveness to infliximab in patients with rheumatoid arthritisM Cuchacovich, L Ferreira, M Aliste, et al.
Scandinavian Journal of Rheumatology|March 9, 2007
Tumour necrosis factor (TNF)alpha -308 G/G promoter polymorphism and TNFalpha levels correlate with a better response to adalimumab in patients with rheumatoid arthritisM Cuchacovich, L Soto, M Edwardes, et al.
Annals of the Rheumatic Diseases|December 7, 2007
Modulation of established murine collagen-induced arthritis by a single inoculation of short-term lipopolysaccharide-stimulated dendritic cellsL Salazar, O Aravena, P Abello, et al.
Pageof 4